SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Bill Wexler's Profits of DOOM -- Ignore unavailable to you. Want to Upgrade?

To: Russian Bear who wrote (535)3/25/1998 11:08:00 AM
From: Hank  Read Replies (1) | Respond to of 4634
 
Or add to my current position at higher levels. Patent approvals are a finicky thing. If you change the formulation just so, you will get an approval. It's a classic case of "If at first you don't succeed, try try again". I still firmly believe that Vasomax has no chance for FDA approval and there's still the issue of the Immumax patent fraud. I'm not accustomed to taking loses on scams like ZONA and I'm not going to start now.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News